Zydus Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ZYDUS PHARMS, and what generic and branded alternatives to ZYDUS PHARMS drugs are available?
ZYDUS PHARMS has two hundred and seventy-one approved drugs.
There are twenty-three tentative approvals on ZYDUS PHARMS drugs.
Summary for Zydus Pharms
| US Patents: | 0 |
| Tradenames: | 236 |
| Ingredients: | 227 |
| NDAs: | 271 |
Drugs and US Patents for Zydus Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Pharms Usa | SIMVASTATIN | simvastatin | TABLET;ORAL | 077837-005 | Dec 20, 2006 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Zydus Pharms Usa Inc | CARVEDILOL | carvedilol | TABLET;ORAL | 077614-002 | Sep 5, 2007 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Zydus Pharms | DOXYCYCLINE | doxycycline | TABLET;ORAL | 209582-004 | Sep 28, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ZYDUS PHARMS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | for Injection | 100 mcg/vial and 500 mcg/vial | ➤ Subscribe | 2015-04-14 |
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
| ➤ Subscribe | for Injection | 200 mcg/vial | ➤ Subscribe | 2015-05-01 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
